In an aspect of second embodiment, present invention involves the preparation of fusion tag construct of Formula (II) comprising fusion of amino terminal of a synthetic nucleotide of semapeptide with carboxyl terminal of fusion tag construct
Pharmacol Res 1997, 35: 153-157
Though the GLP-1 shortage that initially allowed compounding has ended, "a regulatory loophole" allows compounders to continue to sell copycat versions if they customize the formulations, such as by adding vitamins, Bloomberg reports
Retatrutide is widely studied as a triple receptor agonist, engaging GLP-1, GIP, and glucagon pathways linked to metabolic regulation, appetite signalling, energy balance, glucose metabolism, lipid utilisation, and body composition research
While this contributes to satiety and weight loss, it also produces nausea, bloating, and constipation